Modified dual label schilling test for pancreatic exocrine function

Joseph Leung, R. A. Frost, R. Burgess, J. M. Braganza, D. M. Slater, P. B. Cotton

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The modified dual-label Schilling test, as further developed in kit form by Amersham International plc (UK), has been assessed in two separate centres. Since the outcome was similar in each centre, the results in 66 subjects were amalgamated. Using a cut-off point for the 58Co/57Co ratio of 0.52 - as derived from studies in 10 healthy volunteers - to separate normal from abnormal results, the specificity of the test was 88%. However, the test's sensitivity in chronic pancreatic disease was only 50%: normal results occurred in 5 of 8 patients with pancreatic cancer (including 2 with steatorrhoea), and 9 of 21 with chronic pancreatitis (including 1 with steatorrhoea). The possible reasons for the test's poor sensitivity are discussed.

Original languageEnglish (US)
Pages (from-to)93-100
Number of pages8
JournalClinica Chimica Acta
Volume174
Issue number1
DOIs
StatePublished - May 13 1988
Externally publishedYes

Fingerprint

Schilling Test
Steatorrhea
Labels
Pancreatic Diseases
Chronic Pancreatitis
Pancreatic Neoplasms
Healthy Volunteers
Chronic Disease

Keywords

  • BT PABA/C-PABA test
  • Dual label Schilling test
  • Tubeless pancreatic function test

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry

Cite this

Leung, J., Frost, R. A., Burgess, R., Braganza, J. M., Slater, D. M., & Cotton, P. B. (1988). Modified dual label schilling test for pancreatic exocrine function. Clinica Chimica Acta, 174(1), 93-100. https://doi.org/10.1016/0009-8981(88)90369-5

Modified dual label schilling test for pancreatic exocrine function. / Leung, Joseph; Frost, R. A.; Burgess, R.; Braganza, J. M.; Slater, D. M.; Cotton, P. B.

In: Clinica Chimica Acta, Vol. 174, No. 1, 13.05.1988, p. 93-100.

Research output: Contribution to journalArticle

Leung, J, Frost, RA, Burgess, R, Braganza, JM, Slater, DM & Cotton, PB 1988, 'Modified dual label schilling test for pancreatic exocrine function', Clinica Chimica Acta, vol. 174, no. 1, pp. 93-100. https://doi.org/10.1016/0009-8981(88)90369-5
Leung, Joseph ; Frost, R. A. ; Burgess, R. ; Braganza, J. M. ; Slater, D. M. ; Cotton, P. B. / Modified dual label schilling test for pancreatic exocrine function. In: Clinica Chimica Acta. 1988 ; Vol. 174, No. 1. pp. 93-100.
@article{0e2a6083576744a88611bf7f68ae9c61,
title = "Modified dual label schilling test for pancreatic exocrine function",
abstract = "The modified dual-label Schilling test, as further developed in kit form by Amersham International plc (UK), has been assessed in two separate centres. Since the outcome was similar in each centre, the results in 66 subjects were amalgamated. Using a cut-off point for the 58Co/57Co ratio of 0.52 - as derived from studies in 10 healthy volunteers - to separate normal from abnormal results, the specificity of the test was 88{\%}. However, the test's sensitivity in chronic pancreatic disease was only 50{\%}: normal results occurred in 5 of 8 patients with pancreatic cancer (including 2 with steatorrhoea), and 9 of 21 with chronic pancreatitis (including 1 with steatorrhoea). The possible reasons for the test's poor sensitivity are discussed.",
keywords = "BT PABA/C-PABA test, Dual label Schilling test, Tubeless pancreatic function test",
author = "Joseph Leung and Frost, {R. A.} and R. Burgess and Braganza, {J. M.} and Slater, {D. M.} and Cotton, {P. B.}",
year = "1988",
month = "5",
day = "13",
doi = "10.1016/0009-8981(88)90369-5",
language = "English (US)",
volume = "174",
pages = "93--100",
journal = "Clinica Chimica Acta",
issn = "0009-8981",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Modified dual label schilling test for pancreatic exocrine function

AU - Leung, Joseph

AU - Frost, R. A.

AU - Burgess, R.

AU - Braganza, J. M.

AU - Slater, D. M.

AU - Cotton, P. B.

PY - 1988/5/13

Y1 - 1988/5/13

N2 - The modified dual-label Schilling test, as further developed in kit form by Amersham International plc (UK), has been assessed in two separate centres. Since the outcome was similar in each centre, the results in 66 subjects were amalgamated. Using a cut-off point for the 58Co/57Co ratio of 0.52 - as derived from studies in 10 healthy volunteers - to separate normal from abnormal results, the specificity of the test was 88%. However, the test's sensitivity in chronic pancreatic disease was only 50%: normal results occurred in 5 of 8 patients with pancreatic cancer (including 2 with steatorrhoea), and 9 of 21 with chronic pancreatitis (including 1 with steatorrhoea). The possible reasons for the test's poor sensitivity are discussed.

AB - The modified dual-label Schilling test, as further developed in kit form by Amersham International plc (UK), has been assessed in two separate centres. Since the outcome was similar in each centre, the results in 66 subjects were amalgamated. Using a cut-off point for the 58Co/57Co ratio of 0.52 - as derived from studies in 10 healthy volunteers - to separate normal from abnormal results, the specificity of the test was 88%. However, the test's sensitivity in chronic pancreatic disease was only 50%: normal results occurred in 5 of 8 patients with pancreatic cancer (including 2 with steatorrhoea), and 9 of 21 with chronic pancreatitis (including 1 with steatorrhoea). The possible reasons for the test's poor sensitivity are discussed.

KW - BT PABA/C-PABA test

KW - Dual label Schilling test

KW - Tubeless pancreatic function test

UR - http://www.scopus.com/inward/record.url?scp=0023950849&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023950849&partnerID=8YFLogxK

U2 - 10.1016/0009-8981(88)90369-5

DO - 10.1016/0009-8981(88)90369-5

M3 - Article

C2 - 3383440

AN - SCOPUS:0023950849

VL - 174

SP - 93

EP - 100

JO - Clinica Chimica Acta

JF - Clinica Chimica Acta

SN - 0009-8981

IS - 1

ER -